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Objective. To investigate the associations of serum
total and HDL cholesterol with the risk of myocardial
infarction in men and women of 55 years and over.
Design. The Rotterdam Study is a population-based
prospective cohort study. In total 2453 men and
3553 women of 55 years and older were included in
this study. The mean duration of follow-up was
4 years.
Main outcome measures. Relative risks were esti-
mated with Cox's proportional-hazard analysis.
Cholesterol was analysed as a continuous variable
and in sex-specific quartiles.
Results. In subjects aged 55 years and older the
relative risk of myocardial infarction was 1.9 in men
(95% confidence interval 1.1±3.3) and 3.2 in
women (1.5±6.4) in the highest compared to the
lowest serum total cholesterol quartile (Q4 vs. Q1).
In men and women of 70 years and older, total
cholesterol remained an important risk factor for
myocardial infarction (Q4 vs. Q1 relative risk 3.2;
1.3±7.7 and 2.9; 1.3±6.6, respectively). For HDL
cholesterol, the relative risk in the highest compared
to the lowest quartile (Q4 vs. Q1) was 0.5 in men
(0.3±0.9) and 0.4 in women (0.2±0.9). HDL
cholesterol was a weaker predictor in men after
the age of 70 (Q4 vs. Q1 0.8; 0.3±2.1). In women of
70 years and older the relative risk was also not
significant (Q4 vs. Q1 0.6; 0.3±1.3), although the
trend over the quartiles was still significant.
Conclusion. Serum total cholesterol remains an
important risk factor for myocardial infarction in
men and women aged 70 years and older, whilst
HDL cholesterol at older age remains important in
women only.
Keywords: cholesterol, myocardial infarction, el-
derly, prospective study, risk.
Introduction
Several prospective studies have shown that serum
total cholesterol and HDL cholesterol are important
independent risk factors for coronary heart disease
in middle-aged men and women [1±5]. However,
the relationship between cholesterol and coronary
heart disease in elderly subjects is less well
established. Some studies have found that serum
total and HDL cholesterol are important risk factors
for coronary heart disease in the elderly [6±10],
whilst others have noted that the risk weakens with
increasing age [11, 12], or even disappears [13]. For
the discussion about treatment of elevated
cholesterol levels in the elderly it is important to
know whether the relationship between cholesterol
and coronary heart disease still holds in this age
group.
In the Rotterdam Study we have investigated
serum total cholesterol, HDL cholesterol and the
ratio of non-HDL to HDL cholesterol as risk factors
for myocardial infarction in men and women of
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55 years and over. In addition, separate analyses
were performed in men and women of 70 years and
older.
Methods
Study population
The Rotterdam Study is a population-based prospec-
tive cohort study amongst 7983 men and women
aged 55 years and over, living in an urban district of
Rotterdam, The Netherlands. The rationale and
design of the study have been described previously
[14]. In short, the Rotterdam Study investigates the
prevalence, incidence, and determinants of cardio-
vascular, neurological, locomotor, and ophthalmo-
logical diseases at older age. Baseline measurements
were carried out from July 1989 to July 1993. The
overall response rate was 78%. The study has been
approved by the Medical Ethics Committee of the
Erasmus University and written informed consent
was obtained from all participants.
A total of 7129 subjects visited the research
centre. Cholesterol measurements were available for
2554 men and 3789 women. Subjects with
incomplete data for the potential confounders, i.e.
systolic blood pressure, body mass index and
smoking (101 men and 236 women), were ex-
cluded. For 728 men and 1307 women dietary data
were not available. For alcohol, these missing values
were substituted by the sex-specific median of the
alcohol intake for each 5-year age group. The data
of 2453 men and 3553 women were used in the
present analyses.
Measurements
The participants were interviewed in their homes by
trained research assistants. Information on current
health status, medical history (including myocardial
infarction), medication use, and smoking behaviour
was obtained by a computerized questionnaire. A
history of myocardial infarction was considered
positive if the subject reported to have been
hospitalized for this condition.
The home interview was followed by two visits at
the research centre. During those visits several
cardiovascular risk indicators were determined.
Height and weight were measured, and body mass
index was calculated (kg m22). Blood pressure was
measured on the right upper arm with the
participant in a sitting position using a random zero
sphygmomanometer. The first and fifth Korotkoff
phases were recorded as systolic and diastolic blood
pressure. The average of two consecutive measure-
ments was used to calculate the diastolic and systolic
blood pressure. The mean alcohol consumption
(g day21) was calculated from a semiquantitative
food frequency questionnaire. Serum total
cholesterol was determined by an automated enzy-
matic procedure in a nonfasting blood sample [15].
HDL was measured after precipitation of the non-
HDL fraction with phosphotungstate-magnesium.
All cholesterol measurements were carried out in
the laboratory of the Department of Epidemiology &
Biostatistics (Erasmus University Medical School),
which participates in the Dutch National Cholesterol
Standardization Program, initiated in analogy to the
program of the CDC Lipid Standardization Labora-
tory in Atlanta. The cholesterol ratio was defined as
the concentration of non-HDL cholesterol divided by
HDL cholesterol. Hypercholesterolemia was defined
as a serum total cholesterol concentration of
6.5 mmol L21 or higher.
Follow-up
The follow-up started at the baseline examination
and lasted until 1 April 1996. The mean follow-up
was 4.2 years, ranging from 3.0 to 6.5 years. With
respect to the vital status of participants, informa-
tion was obtained at regular intervals from the
municipal registry in Rotterdam. Information on
fatal and nonfatal endpoints was obtained weekly
from the general practitioners working in the study
district and yearly from the general practitioners
working outside the study district. All the reported
events were verified by research physicians from the
Rotterdam Study by examining patient records of
the participating general practitioners. All general
practitioners working outside the study district, who
had patients who participated in the Rotterdam
Study, were visited to obtain information on the
occurrence of nonfatal and fatal events. Cause and
circumstances of death were established shortly after
deaths were reported by the municipal registry or
the general practitioner. A questionnaire was sent to
the general practitioner concerning the cause of
death. Overall, complete follow-up information was
available for 7054 subjects (88.4%) in the present
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study. Participants for whom no follow-up informa-
tion was available were on average 3 years older,
had a 0.1 mmol L21 lower total cholesterol con-
centration and a 0.04 mmol L21 higher HDL
cholesterol concentration.
Classification of fatal and nonfatal events was
based on the 10th revision of the International
Classification of Diseases [16]. Myocardial infarction,
fatal and nonfatal, was defined as ICD-10: I21±24.
All events were classified independently by two
research physicians. If there was disagreement, a
consensus was reached in a special session. Finally,
all these events were verified by a medical expert in
the field of cardiovascular diseases. In case of
discrepancies, the judgement by this expert was
considered definite.
Statistical analyses
Differences in risk factor levels at baseline between
men and women were tested using Student's t-test.
The Mann±Whitney test was used in case the risk
factor distributions were skewed. For differences in
levels of categorical variables (smoking) the x2-test
statistic was calculated.
Cox's proportional-hazard (survival) analysis was
used to estimate relative risks (RRs) and their 95%
confidence limits with myocardial infarction, fatal
and nonfatal, as the dependent variable. Fatal and
nonfatal myocardial infarction were not analysed
separately because of the small number of cases in
this study. Separate analyses were carried out using
total cholesterol, HDL cholesterol and the non-HDL/
HDL cholesterol ratio as the independent variables.
Cholesterol was analysed both as a continuous
variable, for 1.0 mmol L21 increase in total
cholesterol, 0.1 mmol L21 increase in HDL
cholesterol and 1 unit increase in the cholesterol
ratio, and as a categorical variable calculated for
each sex-specific quartile, with the lowest quartile as
the reference category. Because total and HDL
cholesterol were measured in one decimal, the total
number of respondents in each cholesterol quartile
was not completely equal. In all analyses, adjust-
ments were made for age (years), cigarette smoking
(never, former and current), systolic blood pressure
(mmHg) and body mass index (kg m22). For HDL
cholesterol and the cholesterol ratio, adjustment was
also made for alcohol consumption (g day21). All
the analyses were carried out separately for men and
women. The analyses were repeated in men and
women of 70 years and over. The cut-off point of
70 years was used to ensure enough subjects in this
age group. Possible interactions between either total
cholesterol, HDL cholesterol or the cholesterol ratio
and age, cigarette smoking, systolic blood pressure,
body mass index and alcohol consumption were
tested by adding interaction terms to the model.
Analyses were carried out with and without
respondents with a history of myocardial infarction
(12% men and 4% women) and with and without
users of cholesterol lowering medication and/or diet
(3% men and 2% women). Because these results did
not differ and because of the small numbers using
cholesterol lowering medication and/or diet, the
results reported in this article are based on all
subjects.
The number of myocardial infarctions that could
be prevented if the cholesterol levels of all subjects
had been in the lowest, and for HDL cholesterol in
the highest, cholesterol quartile were calculated as
population-attributable risks (PARs). PARs were
calculated using the following formula [17]:
PAR  SiCF iRRiÿ1=RRi
where CF is the proportion of cases with myocardial
infarction, RR is the relative risk and i is the quartile
number. The summation ranged over all the
cholesterol quartiles with the lowest quartile as the
reference category.
The deviance (i.e. log likelihood) from the different
survival models was compared to test whether total
cholesterol, HDL cholesterol or the cholesterol ratio
was the best predictor of myocardial infarction in
our study. The smaller the deviance the better the
prediction of the model.
Results
During 4 years of follow-up, 117 men and 76
women experienced a first or recurrent myocardial
infarction of which 20 were fatal in men and 19
were fatal in women.
Baseline characteristics of the total study popula-
tion are shown in Table 1. The mean serum total
and HDL cholesterol levels at baseline were sig-
nificantly lower in men than in women. The non-
HDL/HDL cholesterol ratio was significantly higher
in men compared to women. The prevalence of
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hypercholesterolemia (total cholesterol $6.5 mmol
L21) was 43% in men and 62% in women. In men
aged 70 years and older the mean age was
76.7 years (range: 70.0±97.8 years) and in women
aged 70 years and older the mean age was
78.0 years (range: 70.0±98.6 years).
In both men and women the relative risk of
myocardial infarction increased with increasing
total cholesterol concentration in both age cate-
gories (Table 2). The age-adjusted relative risk of
myocardial infarction in the highest compared to the
lowest total cholesterol quartile was almost twice as
high in men and more than three times higher in
women aged 55 years and over. In men and women
aged 70 years and over, the age-adjusted relative
risk of myocardial infarction was about three times
higher in the highest compared to the lowest total
cholesterol quartile. Further adjustment for systolic
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Table 1 Baseline characteristics (mean (SD)) of men and women aged 55 years and over in the Rotterdam Study
Men (n = 2453) Women (n = 3553)
Age (years) 68.3 (8.1) 69.7 (9.1)*
Total cholesterol (mmol L21) 6.32 (1.16) 6.85 (1.21)*
HDL cholesterol (mmol L21) 1.21 (0.32) 1.43 (0.36)*
Non-HDL/HDL cholesterol ratio 4.52 (1.62) 4.08 (1.61)*
Systolic blood pressure (mmHg) 139 (22) 140 (22)
BMI (kg m22) 25.7 (3.0) 26.8 (4.1)*
Alcohol drinking (% >0 g day21) 87.4 73.6*
Alcohol consumption (g day21)a 15.7 (18.1) 5.5 (9.7)*
Smoking (%)
current 25.3 18.2*
former 58.5 28.3
Hypercholesterolemia (%)b 42.5 61.8*
History of myocardial infarction (%) 12.4 3.9*
Cholesterol lowering medication (%)c 2.9 2.3
aAmongst alcohol drinkers. bSerum total cholesterol $ 6.5 mmol L21. cInformation available for 2379 men and 2463 women. *P < 0.001,
significantly different between men and women.
Table 2 Adjusteda relative risks (RR) (95% confidence intervals (CI)) of fatal and nonfatal myocardial infarction associated with total
cholesterol in the total population of men and women ($55 years) and in the population aged $70 years in the Rotterdam Study
Total group
$55 years $70 years
Quartile (mmol L21) Mean
Total
number
Number
of events
RR (95% CI) Total
number
Number
of events
RR (95% CI)
Men
#5.4 4.9 565 19 1.00 290 8 1.00
5.5±6.2 5.9 659 30 1.45 (0.81±2.59) 263 14 2.09 (0.87±5.01)
6.3±7.0 6.6 620 33 1.75 (0.98±3.10) 219 16 2.89 (1.22±6.82)
>7.0 7.8 609 35 1.88 (1.06±3.33) 176 14 3.17 (1.31±7.67)
per 1.0 mmol L21
increase
2453 117 1.20 (1.03±1.41) 948 52 1.42 (1.13±1.79)
Women
#5.9 5.3 803 10 1.00 421 8 1.00
6.0±6.7 6.4 937 13 1.14 (0.50±2.61) 428 11 1.26 (0.50±3.17)
6.8±7.5 7.1 895 18 1.68 (0.76±3.68) 375 11 1.37 (0.54±3.50)
>7.5 8.4 918 35 3.15 (1.54±6.42) 408 24 2.93 (1.29±6.62)
per 1.0 mmol L21
increase
3553 76 1.40 (1.20±1.65) 1632 54 1.36 (1.12±1.65)
aAdjusted for age, systolic blood pressure, body mass index and smoking.
blood pressure, body mass index and smoking did
not change the risk estimates.
The relative risk of myocardial infarction de-
creased with increasing HDL cholesterol concentra-
tion in both age categories in women and in men
aged 55 years and over (Table 3). The age-adjusted
relative risk of myocardial infarction in the highest
quartile was less than half that of the lowest quartile
in both men and women aged 55 years and over. In
subjects aged 70 years and older the age-adjusted
relative risk of myocardial infarction was more than
15% lower in men and almost 40% lower in women
in the highest compared to the lowest HDL
cholesterol quartile. The risk estimates did not
change after further adjustment for systolic blood
pressure, body mass index, smoking and alcohol
consumption.
There was a positive trend in relative risk of
myocardial infarction with increase of the non-HDL/
HDL cholesterol ratio in both age categories
(Table 4). The age-adjusted relative risk in the
highest compared to the lowest quartile, was more
than three times higher in both men and women of
55 years and older and in men and women aged
70 years and over.
The mortality rates of myocardial infarction in
men and women aged 55 years and over per
quartile of total cholesterol are given in Fig. 1. In
both sexes, the mortality rate increased with higher
cholesterol concentrations. The mortality rates were
about twice as high in men compared to women at
all levels of total cholesterol, whereby the mortality
rate of the highest total cholesterol concentration in
women is comparable to the mortality rate of the
lowest total cholesterol concentration in men.
Population-attributable risks (PARs) indicate that
there would have been 34% fewer cases with
myocardial infarction in men and 43% in women
of 55 years and older if total cholesterol levels in the
whole population were 5.4 mmol L21 or lower in
men and 5.9 mmol L21 or lower in women (lowest
quartiles) (Table 5). If HDL cholesterol levels in the
whole population were 1.4 mmol L21 or higher in
men or 1.7 mmol L21 or higher in women (highest
quartiles) there would have been 48% fewer cases
with myocardial infarction in men and 39% in
women. The PAR for total cholesterol in subjects
aged 70 years and older was higher in men (53%)
and almost similar in women (39%) compared to
subjects aged 55 years and over. The PAR for HDL
cholesterol was lower in both men and women aged
70 years and older (31% and 12%, respectively).
The deviances for the models with total
cholesterol, HDL cholesterol or the non-HDL/HDL
cholesterol ratio were not significantly different,
meaning that no one parameter was significantly
more predictive than the other in men and women
aged 55 years and older.
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Table 3 Adjusteda relative risks (RR) (95% confidence intervals (CI)) of fatal and nonfatal myocardial infarction associated with HDL
cholesterol in the total population men and women ($55 years) and in the population aged $70 years in the Rotterdam Study
Total group
$55 years $70 years
Quartile (mmol L21) Mean
Total
number
Number
of events
RR (95% CI) Total
number
Number
of events
RR (95% CI)
Men
#0.9 0.84 496 26 1.00 202 9 1.00
1.0±1.1 1.05 664 39 1.09 (0.66±1.79) 258 16 1.29 (0.56±2.93)
1.2±1.3 1.24 615 35 1.09 (0.65±1.83) 224 17 1.70 (0.75±3.88)
>1.3 1.61 678 17 0.47 (0.25±0.89) 264 10 0.82 (0.32±2.09)
per 0.1 mmol L21 increase 2453 117 0.91 (0.86±0.98) 948 52 0.96 (0.87±1.05)
Women
#1.2 1.06 1152 36 1.00 587 26 1.00
1.3±1.4 1.35 859 19 0.70 (0.40±1.24) 395 11 0.54 (0.26±1.13)
1.5±1.6 1.55 694 11 0.57 (0.29±1.13) 292 7 0.51 (0.22±1.19)
>1.6 1.93 848 10 0.44 (0.22±0.91) 358 10 0.62 (0.29±1.32)
per 0.1 mmol L21 increase 3553 76 0.89 (0.83±0.96) 1632 54 0.90 (0.83±0.98)
aAdjusted for age, systolic blood pressure, body mass index, smoking and alcohol consumption.
Discussion
The results of the present study suggest that serum
total cholesterol, HDL cholesterol and the ratio of
non-HDL to HDL cholesterol are important risk
factors for myocardial infarction in men and women
aged 55 years and over. These risk factors remain
important after age 70, except for HDL cholesterol in
men.
Before interpreting the results of our study some
methodological issues will be discussed. First, the
population of the Rotterdam Study was recruited
from an urban district of Rotterdam and had a
somewhat higher social economic status than the
general population. We therefore may not be able to
completely generalize to the general Dutch popula-
tion of 55 years and over. Secondly, the strength of
the association between the cholesterol parameters
and the risk of myocardial infarction is likely to be
underestimated in our study, because the cholesterol
levels were measured only once. A single baseline
cholesterol measurement is subject to random
fluctuations, due to both laboratory measurement
error and biological variation of cholesterol levels in
individuals over time [18]. Thirdly, we had a
relatively short follow-up in this study. Because of
this short follow-up period, we could not exclude
events occurring during the first years of follow-up.
Underlying diseases at baseline could have lowered
the cholesterol levels. However, if this was the case it
would have decreased the relative risks and the true
relative risks would have been even larger. Fourthly,
there was incomplete follow-up information in this
study for 12% of the subjects. This group mainly
consisted of subjects who had a general practitioner
without an automated patient registry, or who had
changed their general practitioner or moved outside
the study district. These factors all contribute to a
retardation in the data collection process. Based on
these main reasons for incomplete follow-up infor-
mation, we expect that the observed differences in
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Table 4 Adjusteda relative risks (RR) (95% confidence intervals (CI)) of fatal and nonfatal myocardial infarction associated with the non-
HDL/HDL cholesterol ratio in the total population men and women ($55 years) and in the population aged $70 years in the Rotterdam
Study
Total group
$55 years $70 years
Quartile (mmol L21) Mean
Total
number
Number
of events
RR (95% CI) Total
number
Number
of events
RR (95% CI)
Men
#3.3 2.7 600 13 1.00 272 7 1.00
3.4±4.3 3.9 666 33 2.34 (1.22±4.47) 279 16 2.25 (0.92±5.52)
4.4±5.3 4.8 532 30 2.80 (1.44±5.44) 188 15 3.27 (1.31±8.15)
>5.3 6.6 655 41 3.24 (1.69±6.19) 209 14 3.06 (1.18±7.91)
per unit increase 2453 117 1.16 (1.05±1.28) 948 52 1.16 (1.01±1.33)
Women
#2.8 2.3 811 8 1.00 359 7 1.00
2.9±3.8 3.4 1021 15 1.45 (0.61±3.43) 474 12 1.29 (0.51±3.29)
3.9±4.8 4.3 844 14 1.43 (0.59±3.48) 376 8 0.90 (0.31±2.57)
>4.8 6.3 877 39 4.00 (1.85±8.65) 423 27 3.24 (1.40±7.53)
per unit increase 3553 76 1.25 (1.16±1.36) 1632 54 1.37 (1.20±1.56)
aAdjusted for age, systolic blood pressure, body mass index, smoking and alcohol consumption.
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Fig. 1 Mortality rates (per 1000 person-years) of myocardial
infarction in men and women aged 55 years and over per sex-
specific total cholesterol quartile in the Rotterdam Study.
baseline characteristics (subjects lost to follow-up
were on average older and had a more favourable
cholesterol profile) have not influenced the relation-
ship between cholesterol and myocardial infarction
in this study.
Results of epidemiological studies on cholesterol
and coronary heart disease in the elderly are
inconsistent. Some studies that examined the
relationship between total cholesterol and coronary
heart disease in men aged 65 years and older found
a positive relationship [7, 8, 10, 11]. However, other
studies reported no association in elderly men [6, 9,
12, 13]. In women aged 65 years and older, two
studies found a positive relationship between total
cholesterol and coronary heart disease [6, 9] and
two studies did not find an association [11, 13]. For
HDL cholesterol, few studies observed an association
with coronary heart disease in men aged 71 years
and older [6, 12]. Most studies found no association
in men aged 65 years and older [9±11, 13]. A
relationship between HDL cholesterol and coronary
heart disease in women with a cut-off age ranging
from 65 to 71 years was seen in three studies [6, 9,
11]. Two other studies did not find an association in
elderly women [12, 13]. Three out of four studies
that have measured the cholesterol ratio observed a
positive relationship with coronary heart disease in
elderly men and women with cut-off ages ranging
from 65 to 71 years [6, 9, 10]. The other study
reported no relationship in subjects older than
70 years [13].
In our study we found a positive relationship
between total cholesterol and myocardial infarction
in men and women aged 70 years and over. The
relative risks for total cholesterol in our study are
higher than those found in most studies mentioned
above when comparable cut-offs were chosen. Only
the Zutphen Elderly Study showed a relative risk of
comparable magnitude for men aged 64 years and
over [10]. We found an inverse relationship between
HDL cholesterol as a continuous parameter and
myocardial infarction in women aged 70 years and
older. The relative risk in the highest HDL
cholesterol quartile compared to the lowest lacked
significance, probably due to the small number of
cases. In men aged 70 years and older the relation-
ship was not present. HDL cholesterol is apparently
not as good a predictor of myocardial infarction in
elderly men as total cholesterol. This is consistent
with other studies which also observed that HDL is
not a strong predictor in older men [9±11, 13],
although two other studies found a clear relation-
ship in men aged 65 years and older [6, 12]. For
women, only the Framingham Study [9] found a
relative risk for HDL cholesterol in women aged
65 years and older comparable in strength to that
observed in our study. The non-HDL/HDL
cholesterol ratio in our study was a good predictor
of myocardial infarction in men and women aged
70 years and older. The relative risks for the
cholesterol ratio observed in our study are compar-
able to those found in the EPESE study [6]; other
studies found weaker associations.
The results of this study showed pronounced
relationships for total cholesterol in men and total
and HDL cholesterol in women at older age. In our
study, we used fatal and nonfatal myocardial
infarction as endpoint rather than coronary heart
disease mortality as used in most other studies in the
elderly. Possibly, the relationship between
cholesterol and incidence of myocardial infarction
is stronger than the relationship between cholesterol
and coronary heart diseases mortality. Another
explanation could be that most other studies have
excluded cases with coronary heart disease at
baseline. However, we have carried out analyses
C H O L E S T E R O L A N D M Y O C A R D I A L I N F A R C T I O N 3 1
# 1999 Blackwell Science Ltd Journal of Internal Medicine 246: 25±33
Table 5 Population-attributable risk (PAR)a of myocardial infarction in the total population men and women ($55 years) and in the
population aged $ 70 years for the cholesterol parameters in the Rotterdam Study
Men Women
Cholesterol parameters $ 55 years $ 70 years $ 55 years $ 70 years
Total cholesterol 34 53 43 39
HDL cholesterol 48 31 39 12
Non-HDL/HDL cholesterol ratio 57 56 50 38
aAssuming that the whole population had levels similar to those of the lowest quartile for total cholesterol and the non-HDL/HDL
cholesterol ratio or the highest quartile for HDL cholesterol.
with and without respondents with myocardial
infarction at baseline and these results did not differ.
We found that total cholesterol, HDL cholesterol
and the cholesterol ratio were all important risk
factors for myocardial infarction in men and women
aged 55 years and older. In this study, the non-
HDL/HDL cholesterol ratio was a slightly better
predictor of myocardial infarction for both men and
women compared with total cholesterol and HDL
cholesterol. However, no one parameter was sig-
nificantly more predictive than the others.
Population-attributable risks (PARs) are deter-
mined by relative risks and prevalences. Usually,
relative risks for coronary heart disease decrease
with advancing age and prevalences of coronary
heart disease increase with age. A decrease in
relative risk does not mean a decline in PAR. The
differences in PARs in this study, in both age groups
and between men and women, depended largely
upon the differences in relative risks found. The PAR
in women aged 55 years and older for total
cholesterol is somewhat higher compared to men.
However, the absolute number of myocardial
infarctions that could be prevented in women would
be smaller than that in men, because of the lower
mortality rates in women (Fig. 1).
Observational studies alone are insufficient to
decide whether the elderly have to be treated for
elevated cholesterol levels or not. An evaluation of
28 randomized clinical trials showed that a lowering
of the plasma cholesterol concentrations is asso-
ciated with a reduction in incidence of coronary
heart disease [19]. There is little experimental data
on cholesterol-lowering strategies in the elderly. The
Scandinavian Simvastatin Survival Study also
showed that in elderly patients with coronary heart
disease (aged 60±70 years) there was a significant
treatment effect (RR 0.7; 95% CI 0.6±0.9) [20].
Whether reduction of cholesterol levels in the elderly
would have a beneficial effect on primary prevention
should be further investigated in clinical trials. The
results of our study indicate that the public health
gain to be achieved in elderly men and women is
potentially large.
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